Early immune responses to intradermal lipopolysaccharide in healthy volunteers: prednisolone’s impact on TLR4-mediated inflammation - Takeaways - MDSpire

Early immune responses to intradermal lipopolysaccharide in healthy volunteers: prednisolone’s impact on TLR4-mediated inflammation

  • By

  • Thomas P. Buters

  • Digna T. de Bruin

  • Pieter W. Hameeteman

  • Wouter ten Voorde

  • Hendrika W. Grievink

  • Michelle Osse

  • Marieke L. de Kam

  • Jeffrey Damman

  • Thierry P. P. van den Bosch

  • Elsa Neubert

  • Robert Rissmann

  • Jacobus Burggraaf

  • Naomi Klarenbeek

  • Manon A. A. Jansen

  • Matthijs Moerland

  • May 20, 2026

  • 0 min

Share

  • 1

    Intradermal lipopolysaccharide (LPS) administration effectively models TLR4-mediated inflammation in human skin.

  • 2

    The study assessed early immune responses to LPS, focusing on IL-1β, neutrophil infiltration, NET formation, and inflammasome activation.

  • 3

    Prednisolone reduced vascular responses and intermediate monocyte infiltration but did not significantly affect early neutrophil responses or cytokine levels.

  • 4

    Neutrophil influx and NET formation were observed as early as 1 hour post-LPS injection, with peak NET formation at 24 hours.

  • 5

    The findings highlight the intradermal LPS model's utility for studying early innate immune responses and evaluating anti-inflammatory therapies.

Original Source(s)

Related Content